| P2093 | author name string | Elliott Richelson | |
| | Mona Boules | |
| | Paul Fredrickson | |
| P2860 | cites work | DARPP-32: regulator of the efficacy of dopaminergic neurotransmission | Q23909380 |
| | Interactions of neurotensin with brain dopamine systems | Q49122106 |
| | Response by the neurotensin systems of the basal ganglia to cocaine treatment. | Q51757747 |
| | Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. | Q51876339 |
| | Neurotensin blocks certain amphetamine-induced behaviours | Q59096318 |
| | Effects of prolonged administration of neurotensin, arginine-vasopressin, NPY, and bombesin on blood TSH, T3 and T4 levels in the rat | Q67260687 |
| | Anorectic effect of calcitonin, neurotensin and bombesin infused in the area of the rostral part of the nucleus of the tractus solitarius in the rat | Q68033265 |
| | Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat | Q69355247 |
| | Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients | Q70122278 |
| | Neurotensin-induced hypothermia: evidence for an interaction with dopaminergic systems and the hypothalamic--pituitary--thyroid axis | Q70529274 |
| | Differential neurobehavioral effects of neurotensin and structural analogues | Q70955205 |
| | Heterogeneity of melanized neurons expressing neurotensin receptor messenger RNA in the substantia nigra and the nucleus paranigralis of control and Parkinson's disease brain | Q72119380 |
| | Neurotensin: perchance an endogenous neuroleptic? | Q72431662 |
| | Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment | Q72533931 |
| | Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol | Q73455068 |
| | Highly potent neurotensin analog that causes hypothermia and antinociception | Q73525799 |
| | The DARPP-32 knockout mouse | Q73553190 |
| | Neurotensin and neurotensin receptors | Q28138527 |
| | Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies | Q33662343 |
| | Does neurotensin mediate the effects of antipsychotic drugs? | Q33704191 |
| | Neurotensin: peptide for the next millennium | Q34060785 |
| | Neurotensin regulates DARPP-32 thr34 phosphorylation in neostriatal neurons by activation of dopamine D1-type receptors | Q34133265 |
| | Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence | Q34245314 |
| | Persistence of neurochemical changes in dopamine systems after repeated cocaine administration | Q34321202 |
| | Neurotensin analogs indications for use as potential antipsychotic compounds | Q34534010 |
| | Neurotensin: specific binding to synaptic membranes from rat brain | Q35025874 |
| | Distribution of neurotensin receptors in mammalian brain. What it is telling us about its interactions with other neurotransmitter systems | Q35273394 |
| | The effects of nicotine on locomotor activity in non-tolerant and tolerant rats | Q36097530 |
| | The neurobiology of neurotensin: focus on neurotensin-dopamine interactions | Q36466127 |
| | Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin | Q39109781 |
| | On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine | Q39725108 |
| | Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients | Q40808959 |
| | The neurotensin receptor: is there more than one subtype? | Q41097997 |
| | Neurotensin: Antinocisponsive action in rodents | Q41445511 |
| | The effect of thyroid hormones in vitro and in vivo on hypothalamic neurotensin release and content | Q41569997 |
| | Functional and pharmacological aspects of central neuropeptidergic transmission mediated by neurotensin and neuromedin n. | Q41764021 |
| | The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition | Q42167718 |
| | Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies | Q42254857 |
| | Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists. | Q42497176 |
| | Neurotensin, a central nervous system peptide: apparent receptor binding in brain membranes | Q43565652 |
| | Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism | Q43703205 |
| | A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity | Q43722020 |
| | Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats | Q43775747 |
| | Neurotensin analog NT69L induces rapid and prolonged hypothermia after hypoxic ischemia | Q43815665 |
| | Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization | Q43829041 |
| | Chronic cocaine administration and withdrawal of cocaine modify neurotensin binding in rat brain | Q43840389 |
| | Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence | Q43866490 |
| | Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats | Q44260116 |
| | Increased glucose production following neurotensin administration | Q44666616 |
| | Extensive co-localization of neurotensin with dopamine in rat meso-cortico-frontal dopaminergic neurons | Q45106345 |
| | A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents | Q47239028 |
| | CCK and other peptides modulate hypothalamic norepinephrine release in the rat: dependence on hunger or satiety | Q48294238 |
| | Central nervous system neurotensin and feeding | Q48389299 |
| | The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia | Q48421817 |
| | Effects of peripheral neurotensin on behavior of the rat | Q48536077 |
| | Central administration of neurotensin stimulates hypothalamic-pituitary-adrenal activity. The paraventricular CRF neuron as a critical site of action | Q48597836 |
| | Parkinson's disease: depletion of substantia nigra neurotensin receptors | Q48635344 |
| | Neurotensin: effects of hypothalamic and intravenous injections on eating and drinking in rats | Q48785650 |
| | Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain | Q48860357 |
| | Effect of centrally administered neurotensin on multiple feeding paradigms | Q49070358 |
| | The effect of neurotensin on food consumption in the rat. | Q49083981 |
| | The effects of neurotensin on anterior pituitary hormone secretion | Q49087279 |
| | Effects of neurotensin on regional brain concentrations of dopamine, serotonin and their main metabolites | Q49092167 |
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nerve tissue protein | Q6996861 |
| P304 | page(s) | 2785-2792 | |
| P577 | publication date | 2003-10-01 | |
| | 2003-10-17 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | Current topics: brain penetrating neurotensin analog | |
| P478 | volume | 73 | |